159 related articles for article (PubMed ID: 32090434)
1. Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA.
Campbell PT; VanWagner LB; Colangelo LA; Lewis CE; Henkel A; Ajmera VH; Lloyd-Jones DM; Vaughan DE; Khan SS
Liver Int; 2020 May; 40(5):1111-1120. PubMed ID: 32090434
[TBL] [Abstract][Full Text] [Related]
2. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
[TBL] [Abstract][Full Text] [Related]
3. Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study.
Cleveland ER; Ning H; Vos MB; Lewis CE; Rinella ME; Carr JJ; Lloyd-Jones DM; VanWagner LB
J Gen Intern Med; 2019 Dec; 34(12):2772-2778. PubMed ID: 31595464
[TBL] [Abstract][Full Text] [Related]
4. Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
Li Y; Chen C; Lu L; Guo W; VanWagner LB; Shikany JM; Zhang S; Kahe K
Dig Dis Sci; 2022 Feb; 67(2):689-696. PubMed ID: 33630217
[TBL] [Abstract][Full Text] [Related]
5. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.
Sarkar M; Wellons M; Cedars MI; VanWagner L; Gunderson EP; Ajmera V; Torchen L; Siscovick D; Carr JJ; Terry JG; Rinella M; Lewis CE; Terrault N
Am J Gastroenterol; 2017 May; 112(5):755-762. PubMed ID: 28291240
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Alsharoh H; Ismaiel A; Leucuta DC; Popa SL; Dumitrascu DL
J Gastrointestin Liver Dis; 2022 Jun; 31(2):206-214. PubMed ID: 35574617
[TBL] [Abstract][Full Text] [Related]
7. Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study.
Hatano Y; VanWagner LB; Carnethon MR; Bancks MP; Carson AP; Lloyd-Jones DM; Østbye T; Viera AJ; Yano Y
Diabetologia; 2023 Jul; 66(7):1235-1246. PubMed ID: 36941389
[TBL] [Abstract][Full Text] [Related]
8. Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.
Jin R; Krasinskas A; Le NA; Konomi JV; Holzberg J; Romero R; Vos MB
Pediatr Obes; 2018 Jan; 13(1):23-29. PubMed ID: 27764892
[TBL] [Abstract][Full Text] [Related]
9. Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults.
Lu L; Chen C; Li Y; Guo W; Zhang S; Brockman J; Shikany JM; Kahe K
Eur J Nutr; 2022 Apr; 61(3):1245-1254. PubMed ID: 34741649
[TBL] [Abstract][Full Text] [Related]
10. Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.
VanWagner LB; Khan SS; Ning H; Siddique J; Lewis CE; Carr JJ; Vos MB; Speliotes E; Terrault NA; Rinella ME; Lloyd-Jones DM; Allen NB
Liver Int; 2018 Apr; 38(4):706-714. PubMed ID: 28963767
[TBL] [Abstract][Full Text] [Related]
11. Dietary Patterns and Prevalent NAFLD at Year 25 from the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Gray ME; Bae S; Ramachandran R; Baldwin N; VanWagner LB; Jacobs DR; Terry JG; Shikany JM
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215504
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study.
Gerber Y; VanWagner LB; Yaffe K; Terry JG; Rana JS; Reis JP; Sidney S
BMC Gastroenterol; 2021 Mar; 21(1):96. PubMed ID: 33653293
[TBL] [Abstract][Full Text] [Related]
13. Young Adult Physical Activity Trajectories and Midlife Nonalcoholic Fatty Liver Disease.
de Brito JN; McDonough DJ; Mathew M; VanWagner LB; Schreiner PJ; Gabriel KP; Jacobs DR; Terry JG; Carr JJ; Pereira MA
JAMA Netw Open; 2023 Oct; 6(10):e2338952. PubMed ID: 37862012
[TBL] [Abstract][Full Text] [Related]
14. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease.
Ajmera VH; Gunderson EP; VanWagner LB; Lewis CE; Carr JJ; Terrault NA
Am J Gastroenterol; 2016 May; 111(5):658-64. PubMed ID: 27002796
[TBL] [Abstract][Full Text] [Related]
15. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Verrijken A; Francque S; Mertens I; Prawitt J; Caron S; Hubens G; Van Marck E; Staels B; Michielsen P; Van Gaal L
Hepatology; 2014 Jan; 59(1):121-9. PubMed ID: 24375485
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from periodontal pathogens regulate hepatic steatosis via Toll-like receptor 2 and plasminogen activator inhibitor-1.
Kim HY; Lim Y; Jang JS; Ko YK; Choi Y; Kim HH; Choi BK
J Extracell Vesicles; 2024 Jan; 13(1):e12407. PubMed ID: 38251423
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
Gummesson A; Strömberg U; Schmidt C; Kullberg J; Angerås O; Lindgren S; Hjelmgren O; Torén K; Rosengren A; Fagerberg B; Brandberg J; Bergström G
PLoS One; 2018; 13(8):e0202666. PubMed ID: 30133541
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
[TBL] [Abstract][Full Text] [Related]
19. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.
Long MT; Massaro JM; Hoffmann U; Benjamin EJ; Naimi TS
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1831-1841.e5. PubMed ID: 31734449
[TBL] [Abstract][Full Text] [Related]
20. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
